Related Experiment Video

Updated: May 28, 2025

Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice
06:54

Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice

Published on: November 15, 2024

1.3K

Systemic antihyperalgesic effect of a novel conotoxin from Californiconus californicus in an inflammatory pain model

Joaquín López-Carrillo1, Johanna Bernáldez-Sarabia1, Tushar J Pawar2

  • 1Departamento de Innovación Biomédica, CICESE, Ensenada, Mexico.

Frontiers in Pain Research (Lausanne, Switzerland)
|February 10, 2025
PubMed
Abstract

Insights

A novel conotoxin, O1_cal6.4b, shows potent analgesic effects for inflammatory pain in rats. This conotoxin offers a promising alternative to traditional pain management therapies.

Area of Science:

  • Marine biotechnology
  • Neuroscience
  • Pharmacology

Background:

  • Conotoxins are peptides from cone snails with diverse pharmacological activities.
  • Novel conotoxins are being investigated for therapeutic potential.
  • Inflammatory pain remains a significant challenge in pain management.

Purpose of the Study:

  • To evaluate the analgesic potential of the novel conotoxin O1_cal6.4b.
  • To assess O1_cal6.4b's efficacy in a rat model of inflammatory pain.
  • To compare O1_cal6.4b with other conotoxins and standard analgesics.

Main Methods:

  • Systemic administration of O1_cal6.4b to Wistar rats.
  • Evaluation of thermal hyperalgesia and motor coordination.
  • In silico modeling and molecular dynamics simulations for structural analysis.

Main Results:

  • O1_cal6.4b dose-dependently reduced thermal hyperalgesia without motor impairment.
  • O1_cal6.4b demonstrated superior analgesic effects compared to O1_cal6.4d, ω-MVIIA, and standard analgesics.
  • Structural analysis revealed significant differences between O1_cal6.4b and O1_cal6.4d.

Conclusions:

  • O1_cal6.4b presents a promising analgesic profile for pain management.
  • This conotoxin offers potential advantages over current opioid-based treatments.
  • Further research is warranted to understand O1_cal6.4b's mechanism of action.
Keywords:
Californiconus californicusanalgesiachronic pain treatmentsconotoxin systemic administrationinflammatory pain

More Related Videos

Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies08:16

Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies

Published on: October 6, 2022

6.0K
Chronic Post-Ischemia Pain Model for Complex Regional Pain Syndrome Type-I in Rats07:12

Chronic Post-Ischemia Pain Model for Complex Regional Pain Syndrome Type-I in Rats

Published on: January 21, 2020

7.6K

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
429
Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
27.7K